Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Nicolì, Elena ^a,b   Syga, Marie Isabel ^b   Bosetti, Michela ^a   Shastri, V Prasad ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; ENDONUCLEASE; EXTRACELLULAR ENDONUCLEASE; HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMIN BRANCHED POLYETHYLENEIMINE SMALL INTERFERING RNA TERNARY COMPLEX; POLYETHYLENEIMINE; POLYETHYLENEIMINE SMALL INTERFERING RNA COMPLEX; SMALL INTERFERING RNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; MACROMOLECULE; SERUM ALBUMIN;

ARTICLE; BREAST CANCER CELL LINE; CAPILLARY ENDOTHELIAL CELL; CAVEOLA; CELL MIGRATION; CELL VIABILITY; COMPARATIVE STUDY; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOCYTOSIS; EPITHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELIVERY SYSTEM; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PRIMARY PULMONARY MICROVASCULAR ENDOTHELIAL CELL; IN VITRO STUDY; INTERNALIZATION; MDA MB 231 CELL LINE; MOLECULAR DYNAMICS; MOLECULAR STABILITY; PARTICLE SIZE; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; ENDOTHELIUM CELL; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETICS; MACROMOLECULE; METABOLISM; PHARMACOKINETICS; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

CAVEOLAE; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENE SILENCING; HUMANS; MACROMOLECULAR SUBSTANCES; POLYETHYLENEIMINE; RNA, SMALL INTERFERING; SERUM ALBUMIN;

EID: 84929497325     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122581     Document Type: Article

References (36)

1. O 'Connor TP, Crystal RG. Genetic medicines: treatment strategies for hereditary disorders. Nat Rev Genet. 2006; 7: 261-76. PMID: 16543931
2. Kanasty RL, Whitehead KA, Vegas AJ, Anderson DG. Action and reaction: the biological response to siRNA and its delivery vehicles. Mol Ther. 2012; 20: 513-24. doi: 10.1038/mt.2011.294 PMID: 22252451
3. McDaneld TG. MicroRNA: mechanism of gene regulation and application to livestock. J Anim Sci. 2009; 87: E21-8. doi: 10.2527/jas.2008-1303 PMID: 18791136
4. Bartel DP. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell. 2004; 116: 281-297. PMID: 14744438
5. Kanasty R, Dorkin JR, Vegas A, Anderson D. Delivery materials for siRNA therapeutics. Nat Mater. 2013; 12: 967-77. doi: 10.1038/nmat3765 PMID: 24150415
6. Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, et al. Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci USA. 2014; 111: 11449-54. doi: 10.1073/pnas.1411393111 PMID: 25049380
7. Whitehead K a, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009; 8: 129-38. doi: 10.1038/nrd2742 PMID: 19180106
8. Aigner A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol. 2006; 124: 12-25. PMID: 16413079
9. Malek A, Merkel O, Fink L, Czubayko F, Kissel T, Aigner A. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Toxicol Appl Pharmacol. 2009; 236: 97-108. doi: 10.1016/j.taap.2009.01.014 PMID: 19371615
10. Gatter KC, Brown G, Trowbridget IS, Woolston RE, Mason DY. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol. 1983; 36: 539-545. PMID: 6302135
11. Kratz F, Beyer U. Serum Proteins as Drug Carriers of Anticancer Agents: A Review. Drug Deliv.1998; 5: 281-299. doi: 10.3109/10717549809065759 PMID: 19569996
12. Kim SI, Shin D, Lee H, Ahn B-Y, Yoon Y, Kim M. Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes. J Hepatol. 2009; 50: 479-88. doi: 10.1016/j.jhep.2008. 10.029 PMID: 19155084
13. Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release. 2008; 132: 171-83. doi: 10.1016/j.jconrel.2008.05.010 PMID: 18582981
14. Malik AB. Targeting Endothelial Cell Surface Receptors: Novel Mechanisms of Microvascular Endothelial Barrier Transport. J Med Sci. 2009; 2: 13-17.
15. Han J, Wang Q, Zhang Z, Gong T, Sun X. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer. Small. 2014; 10: 524-35. doi: 10.1002/smll.201301992 PMID: 24106138
16. Singh HD, Wang G, Uludaʇ H, Unsworth LD. Poly-L-lysine-coated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics. Acta Biomater. 2010; 6: 4277-84. doi: 10.1016/j.actbio.2010.06.017 PMID: 20601248
17. Carrabino S, Di Gioia S, Copreni E, Conese M. Serum albumin enhances polyethylenimine-mediated gene delivery to human respiratory epithelial cells. J Gene Med. 2005; 7: 1555-64. PMID: 16028303
18. Rhaese S, Von Briesen H, Rubsamen-waigmann H, Langer K. Human serum albumin-polyethylenimine nanoparticles for gene delivery. J Control Release. 2003; 92: 199-208. PMID: 14499197
19. Abbasi S, Paul A, Prakash S. Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer. Cell Biochem Biophys. 2011; 61: 277-87. doi: 10.1007/s12013-011-9201-9 PMID: 21556941
20. Son S, Song S, Lee SJ, Min S, Kim SA, Yhee JY, et al. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors. Biomaterials. 2013; 34: 9475-85. doi: 10.1016/j.biomaterials.2013.08.085 PMID: 24050874
21. Kang J-H, Tachibana Y, Obika S, Harada-Shiba M, Yamaoka T. Efficient reduction of serum cholesterol by combining a liver-targeted gene delivery system with chemically modified apolipoprotein B siRNA. J Control Release. 2012; 163: 119-24. doi: 10.1016/j.jconrel.2012.08.030 PMID: 22974833
22. Pan T, Xiao Z-D, Huang P-M. Characterize the interaction between polyethylenimine and serum albumin using surface plasmon resonance and fluorescence method. J Lumin, 2009 129: 741-45.
23. Kwok A, Hart SL. Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine. 2011; 7: 210-9. doi: 10.1016/j.nano.2010.07.005 PMID: 20709624
24. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007; 6: 273-286. PMID: 17396134
25. Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009; 9: 274-84. doi: 10.1038/nrc2622 PMID: 19308067
26. Desai N, Trieu V, Damascelli B, Soon-shiong P. SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients. Transl Oncol. 2009; 2: 59-64. PMID: 19412420
27. Schnitzer JE, Oh P. Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium, Am J Physiol. 1992; 263: 1872-9.
28. Kim JA, Åberg C, Salvati A, Dawson KA. Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol. 2011 7: 62-8. doi: 10.1038/nnano.2011.191 PMID: 22056728
29. Galbiati F, Volonté D, Liu J, Capozza F, Frank PG, Zhu L, et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell. 2001; 12: 2229-44. PMID: 11514613
30. Ogris M, Steinlein P, Carotta S, Brunner S, Wagner E. DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS PharmSci. 2001; 3: E21. PMID: 11741272
31. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 2004; 377: 159-69. PMID: 14505488
32. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008; 105: 14265-70. doi: 10.1073/pnas.0805135105 PMID: 18809927
33. Voigt J, Christensen J, Shastri VP. Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc Natl Acad Sci U S A. 2014; 111: 2942-7. doi: 10.1073/pnas. 1322356111 PMID: 24516167
34. Lavie Y, Fiucci G, Liscovitch M. Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv Drug Deliv Rev. 2001; 49: 317-23. PMID: 11551402
35. Rejman J, Bragonzi A, Conese M. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther. 2005; 12: 468-74. PMID: 15963763
36. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem. 1997; 272: 25968-75. PMID: 9325331